122 related articles for article (PubMed ID: 3571941)
1. The prevalence of abnormal involuntary movements among chronic schizophrenics.
Guy W; Ban TA; Wilson WH
Int Clin Psychopharmacol; 1986 Apr; 1(2):134-44. PubMed ID: 3571941
[TBL] [Abstract][Full Text] [Related]
2. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
Owens DG; Johnstone EC; Frith CD
Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
[TBL] [Abstract][Full Text] [Related]
4. Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
Zhang XY; Yu YQ; Sun S; Zhang X; Li W; Xiu MH; Chen DC; Yang FD; Zhu F; Kosten TA; Kosten TR
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1765-9. PubMed ID: 21723906
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
Chacko RC; Root L; Marmion J; Molinari V; Adams GL
J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
[TBL] [Abstract][Full Text] [Related]
6. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia in schizophrenics. Prevalence, distribution and relationship to neurological "soft" signs in Nigerian patients.
Gureje O
Acta Psychiatr Scand; 1987 Nov; 76(5):523-8. PubMed ID: 2893513
[TBL] [Abstract][Full Text] [Related]
8. The Nithsdale schizophrenia survey. V. Follow-up of tardive dyskinesia at 3 1/2 years.
Robinson AD; McCreadie RG
Br J Psychiatry; 1986 Nov; 149():621-3. PubMed ID: 2880631
[TBL] [Abstract][Full Text] [Related]
9. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Tan YL; Zhou DF; Zhang XY
Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
[TBL] [Abstract][Full Text] [Related]
10. Not all that moves is tardive dyskinesia.
Khot V; Wyatt RJ
Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia: age and sex differences in hospitalized schizophrenics.
Smith JM; Oswald WT; Kucharski LT; Waterman LJ
Psychopharmacology (Berl); 1978 Jul; 58(2):207-11. PubMed ID: 98792
[TBL] [Abstract][Full Text] [Related]
12. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
14. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
[TBL] [Abstract][Full Text] [Related]
17. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
[TBL] [Abstract][Full Text] [Related]
18. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of spontaneous dyskinesia in schizophrenia.
Fenton WS
J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia in northern Israel: preliminary study.
Schwartz M; Silver H; Tal I; Sharf B
Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
